Use access key #2 to skip to page content.

IBDvalueinvestin (98.33)

Tiny market cap BSDM gets FDA nod on $2 Billion market potential



August 18, 2010 – Comments (1) | RELATED TICKERS: PRSNQ

Too bad I can't rate it because its under $100M cap but not for long.

“The MTX-180 represents a significant advance in our strategy to diversify BSD’s products and increase revenue,” said Harold Wolcott, BSD President. “The MTX-180 introduces into the Company’s product line an innovative, high-end disposable that is used in each ablation treatment, and will provide a significant ongoing revenue stream. The soft tissue ablation world market potential is estimated to exceed $2 billion. We believe that the MicroThermX System provides significant advantages over currently available devices that will allow us to capitalize on this rapidly expanding market.”

1 Comments – Post Your Own

#1) On August 18, 2010 at 3:18 PM, sarcaz (31.40) wrote:

Do you think this is still a buy after a 185% jump?

Report this comment

Featured Broker Partners